A Phase 2 Randomized, Double-Blind, Placebo-Controlled S

Project: Research project

Description

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients with Charcot- Marie-Tooth Disease Types 1 and X
StatusActive
Effective start/end date2/1/171/31/21

Funding

  • ACCELERON PHARMA INC.

Fingerprint

Charcot-Marie-Tooth Disease
Placebos